Company

About

Aphena Pharma Solutions

Aphena Pharma Solutions

Glasgow, Kentucky, United States

Aphena Pharma Solutions is a large pharma solutions provider focused on contract packaging, repackaging and manufacturing for the pharmaceutical, OTC, dietary supplement, animal health and medical device marketplaces. With over 25 years of experience in pharmaceutical packaging, Aphena was formed in 2011 by a family of well established companies (PrePak Systems, TestPak, Celeste and Integrated Pharmaceutical Packaging). The strategic alliance is now called Aphena Pharma Solutions. Aphena has five FDA registered facilities in the US and offers several capabilities to our customers. Aphena provides clients with a full range of solutions to address their pharmaceutical packaging and manufacturing requirements. With our continued investment in technology, advanced packaging systems and rigorous cost control, we can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the development of a product – including concept, manufacturing, packaging and distribution – we provide clients with services and solutions to help ensure a successful product launch. Our team of seasoned experts collaborates with clients and addresses every aspect of their product. We partner with clients to develop the solutions they need to succeed in a highly competitive marketplace, and we're committed to delivering an end result that is on schedule and cost effective.

Liberate Medical

Liberate Medical

Crestwood, Kentucky, United States

Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders. Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support. VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation. Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider.

Orthopeutics

Orthopeutics

Lexington, Kentucky, United States

Nonsurgical solutions for back problems